JPM
JPMorgan Chase & Co.
stock NYSE

If you like "beaten down" biotechs with massive insider skin in the game, Elutia Inc. ($ELUT) is flashing some major signals. It’s currently trading around $0.70, but multiple analysts have price targets as high as $6.00.
1. THE "SMART MONEY" SIGNAL
In late December 2025, we saw a massive cluster of insider buying. When you see this many high-level execs buying with their own cash at the same time, it’s usually for a reason:
• Kevin Rakin (Director): 50,000 shares
• Matthew Ferguson (CFO): 60,000 shares
• Brigid Makes (Director): 25,000 shares
• Randy Mills (CEO): Consistently adding to his position.
The Bottom Line: These buys happened in the $0.51 - $0.53 range. The current price is only slightly above that, giving us a similar entry to the people running the company.
2. HUGE CATALYST: JP Morgan Week (Happening NOW)
Today, Tuesday, January 13, 2026, Elutia is presenting at the Global BioInnovation Forum (part of the JPM Healthcare conference week).
• Focus: They are providing a deep dive into the NXT-41x program.
• The Opportunity: They are targeting a $1.5 billion breast reconstruction market with a product designed to slash infection rates (which currently plague 25% of patients).
3. FDA ROADMAP (The 2026 Play)
Management has laid out a clear "double-dip" of catalysts for this year:
• H1 2026: Submission of FDA filing for NXT-41 (base matrix).
• H2 2026: Anticipated FDA clearance for NXT-41.
• H1 2027: Clearance for the drug-eluting version, NXT-41x.
4. THE WAR CHEST:
Unlike many penny biotechs, Elutia actually has cash. After selling their BioEnvelope business to Boston Scientific for $88M, they ended 2025 with over $36M in cash. Management states this is enough to fund them through the commercial launch of their next-gen products without further dilution.
VERDICT:
Analysts have an average PT of $4.00 - $6.00 (a 500%+ upside). With a presentation today and insiders buying heavily at $0.50, the risk/reward here is skewed heavily to the upside if they can regain Nasdaq compliance organically.
Position: Long. Watching for a volume spike today during the JPM presentation.
Disclaimer: Not a financial advisor. Micro-cap biotechs are high risk and can go to zero. Do your own DD.

Why is SPY multiplied by percentage directly while JPM multiply by 1.05.
Very dubious coding skill.

if j\_dimon.mention = "cockroach" :
( SPY = SPY.last \* -1% )
elif j\_dimon.mention = "rats" :
( SPY = SPY.last \* -10% )
else :
( JPM = JPM.last \* 1.05 ,
Order = BUY.BUY.BUYYYYYYYY
)
EXECUTE!

Thanks for the tip, but you’re missing the point. This is a long play, could even come out of JPM this week with a de-risking strategic partnership

Reddit, we’ve been tracking the institutional flow, and the latest JPM QuantSignal for the 1-month prediction has just hit a high-conviction threshold.
In a market dominated by algorithmic trading and macro uncertainty, following the quant data isn't just an advantage—it's a necessity. This specific signal focuses on mean reversion and volume-weighted momentum, providing a data-driven edge that retail sentiment often misses.
Why this matters right now:
* We're seeing institutional positioning shift ahead of the monthly close.
* The volatility index suggests a tightening range, often a precursor to a high-velocity move.
* Historical accuracy for this specific model has consistently identified entry points before the broader market reacts.
We aren't just speculating; we're looking at the same signals that desks at the major banks use to hedge their portfolios. This isn't about hype—it's about the math behind the price action.
The full data set, including entry zones, risk parameters, and the logic behind the Katy 1M prediction, is ready for those who want to see the numbers behind the signal.
Full breakdown ready!
🔗 [https://discord.gg/quantsignals](https://discord.gg/quantsignals)...
🔥 Unlock full content: [https://discord.gg/quantsignals](https://discord.gg/quantsignals)
https://preview.redd.it/khj6a5a4q2dg1.png?width=1080&format=png&auto=webp&s=09aff5b224c85a4f27c0db9cb2f395dba0a1c894

**+++ [Etwas auf die Ohren gibt es hier](https://distrokid.com/hyperfollow/monchella420/) +++**
**[US | 🦆 Erntenkalender - aktuelle Woche](https://i.redd.it/k380kxof3ccg1.png)**
**Die Termine aus dem 📅 - 13.01.2026**
|Land|Zeit|Auswirkung|Event|Forecast|Previous|
|:-|:-|:-|:-|:-|:-|
|🇺🇸|14:30|🔴🔴🔴|Verbraucherpreisindex - Kernrate (Monat) (Dez)|0,3%|0,2%
|🇺🇸|14:30|🔴🔴🔴|Verbraucherpreisindex (VPI) (Monat) (Dez)|0,3%|0,3%
|🇺🇸|14:30|🔴🔴🔴|Verbraucherpreisindex (VPI) (Jahr) (Dez)|2,7%|2,7%
|🇺🇸|16:00|🔴🔴🔴|Verkäufe neuer Häuser (Sep)|716K|800K
**Die heutigen Ernten 🦆 - 13.01.2026**
|Aktie|Zeit|Marktkappe|EPS Forecast|His. EPS Beat / Miss|
|:-|:-|:-|:-|:-|
|J P Morgan Chase & Co($JPM)|☀️|$897.77 Mrd.|5.01| ✅ **4** / ❌ **0**|
|The Bank Of New York Mellon Corporation ($BK)|☀️|$83.72 Mrd.|1.97| ✅ **4** / ❌ **0**|
|Delta Air Lines, Inc.($DAL)|☀️|$46.55 Mrd.|1.53| ✅ **4** / ❌ **0**|
**^((**Automatisch erzeugt 🚀🚀)**)**

[JPM](https://www.onvista.de/aktien/JPMorgan-Chase-Aktie-US46625H1005) - JP Morgan Chase 📃@279.2€(+0,38% 🥱)
[BK](https://www.onvista.de/aktien/THE-BANK-OF-NEW-YORK-MELLON-CORP-Aktie-US0640581007) - Bank of New York Mellon 📃@120.66$(+1,36% 🤑)
[DAL](https://www.onvista.de/aktien/DELTA-AIR-LINES-INC-Aktie-US2473617023) - Delta Air Lines 📃@60.91€(+0,25% 🥱)

I sold a put on JPM expiring this Friday. Hopefully earnings tomorrow don’t make me regret it
Also sold puts on klarna and affirm

Yeah. Meanwhile, another bio stock goes up $5 today on speculation during JPM week.
You decide what play you want to go with

Earnings are starting to roll in! I have developed this calendar of all S&P 500 events that I wanted to share. It includes historical average price volatility per each stock:[](https://preview.redd.it/s-p-500-earnings-lookahead-jan-2026-v0-pyjogjphptcg1.png?width=2956&format=png&auto=webp&s=baa4e866fc9abe7c4b0e97fe93b869fc3abb4d94)
[S&P 500 Earnings Calendar: Jan 2026](https://preview.redd.it/j8n2up92yzcg1.png?width=2962&format=png&auto=webp&s=0274b801840569f244e065d0b1cfcb4826c6cd95)
I highlighted top three highest volatility events in orange \^
# Highest expected volatility events
*(... And what I think are the key debates this quarter):*
* **MMM (Jan 20 | \~9.0%)** 
* Exposure to AI-linked demand for materials and data-center infrastructure e.g. cooling liquid
* **INTC (Jan 22 | \~9.1%)** 
* Government support, execution under the U.S. AI chip strategy, and Intel’s ability to reclaim relevance
* **CHTR (Jan 30 | \~11.8%)**
* Referendum on U.S. broadband demand
# What Polymarket is pricing for banks
*(as of 12th Jan EOD)*
Prediction markets are currently skewed toward **positive EPS beats** for U.S. banks next week:
* **JPM:** \~53% chance to beat (although big drop from yest.)
* **GS:** \~92%
* **WFC:** \~77%
* **MS:** \~82%
* **BAC:** \~80%
* **C:** \~53%
Here’s what investors will be watching by sector 👇
# Banks
The most debated topic may be **Trump’s proposed 10% cap on card commissions**.
However structured, such a policy would pressure **credit card profitability and credit availability**, making management commentary critical.
Other focus areas:
* Mortgage activity and consumer credit trends
* Net interest margin trajectory
* Capital return outlook
# Big Tech & Platforms
Two major debates dominate:
**1) AI spend discipline vs ROI**
* Capex trajectory: another year of aggressive data-center build, or moderating spend growth?
* Monetisation proof points: where AI is translating into revenue (cloud consumption, ad efficiency, subscriptions, devices/services)
**2) The next AI bottleneck**
* Is it **compute, power, memory, cooling, networking, or materials**?

What are the key names and debates for you?

Be brave apes - more stock was withdrawn on the latest CME Silver Stock reports.
shitty scenario for the CME - 27.8% of registered stock is matched for delivery this month too + fall in eligible stock to replenish means stock is tiiiight aight
Details on the inventory moves and which warehouse here:
Silver (CME) — Jan 09: Total inventory fell 0.52% (net -2.26M oz) due to physical withdrawals.
Total
437.49M
🔻 -2.26M
Registered
123.50M
🔻 -399K
Eligible
313.99M
🔻 -1.86M
• Stonex Precious Metals LLC: withdrew \~792K oz from eligible → physical metal exited CME stocks (tightening if persistent).
• Brinks Inc.: withdrew \~618K oz from eligible → physical metal exited CME stocks (tightening if persistent).
• Jp Morgan Chase Bank Na: withdrew \~436K oz from eligible → physical metal exited CME stocks (tightening if persistent). - JPM has consistently moved stock every day in Jan!!
• Cnt Depository Inc.: withdrew \~351K oz from registered → physical metal exited CME stocks (tightening if persistent).
Registered stocks fell (delivery tightness).
I have all major indicators, news feeds, inventory analysis and pressure analysis + 25 years hostiric data for pattern matching on precious metals on a personal dashboard i have built for myself if yo want peeks let me know by DM. The above image is a lickle snapshot of a section from it.

Totalreturns.com comparison: JPM>SPMO>QQQ>VOO. I Started a position in SPMO to complement SCHG and SPYM. I Will probably also add JPM ( 37% 1yr return) and see.

$ATON: $ATON Just Dropped a $46M NVIDIA Deal at JPM — The Biotech-to-AI Pivot is Real.

Calls: BK DAL
Puts: JPM

JPM in the morning

Definitely.
Banks that issue credit cards (C, JPM, WFC, etc.) are. Plus, they have been on a tear heading into earnings so some are probably locking in profits.

Is JPM an oil company ( drill baby drill), a AI/Tech company or a Bank these days? Hell it could be a Healthcare company. I just don’t know what the company I’m watching even do anymore.

JPM QuantSignals V3: Early 2026 Earnings Outlook and Institutional Positioning

Tweet Mirror:[FirstSquawk](https://twitter.com/FirstSquawk/status/2010778056903037211)
>PFIZER CEO SAYS NEXT\-GEN OBESITY ASSETS FROM METSERA BUYOUT EXPECTED TO LAUNCH IN 2028 – JPM CONF

BHVN update at JPM HC looks very promising for a long term play. Been a series of misses for them recently.